Ascendis Pharma SG&A Expense (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

120.97 -1.83 (-1.49%) USD | NASDAQ | May 17, 16:00

120.97 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	72.54M
December 31, 2023	68.90M
September 30, 2023	69.26M
June 30, 2023	76.64M
March 31, 2023	71.47M
December 31, 2022	57.83M
September 30, 2022	61.12M
June 30, 2022	60.27M
March 31, 2022	53.21M
December 31, 2021	55.25M
September 30, 2021	46.32M
June 30, 2021	42.60M
March 31, 2021	44.88M
December 31, 2020	24.35M
September 30, 2020	20.49M
June 30, 2020	22.91M
March 31, 2020	19.77M
December 31, 2019	18.91M
September 30, 2019	11.12M
June 30, 2019	12.31M
March 31, 2019	11.85M

Date	Value
December 31, 2018	9.553M
September 30, 2018	7.902M
June 30, 2018	6.24M
March 31, 2018	5.727M
December 31, 2017	4.812M
September 30, 2017	3.339M
June 30, 2017	3.555M
March 31, 2017	3.542M
December 31, 2016	3.545M
September 30, 2016	2.948M
June 30, 2016	3.015M
March 31, 2016	3.208M
December 31, 2015	3.797M
September 30, 2015	1.551M
June 30, 2015	2.369M
March 31, 2015	2.714M
December 31, 2014	2.955M
September 30, 2014	2.062M
June 30, 2014	1.930M
March 31, 2014	1.295M
December 31, 2013	0.7514M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

11.12M

Minimum

Sep 2019

76.64M

Maximum

Jun 2023

45.51M

Average

49.76M

Median

SG&A Expense (Quarterly) Benchmarks